William Carson work email
- Valid
- Valid
- Valid
William Carson personal email
William Carson phone numbers
With over 10 years of board leadership and pharmaceutical executive experience, I am passionate about developing and commercializing innovative therapies that improve the lives of patients and society. I currently serve as the Chairman of the Board at Decibel Therapeutics (NASDAQ: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders.In addition, I am an Independent Board Director at Annexon Biosciences (NASDAQ: ANNX), a clinical-stage biopharmaceutical company developing novel therapies for autoimmune and neurodegenerative diseases; a Board Director at Excision BioTherapeutics, a gene therapy company focused on curing viral infectious diseases; and a Board Director at Lutron, a leader in smart lighting and shading solutions. I also hold a Corporate Director Certification from Harvard Business School Executive Education, and I have extensive experience in executive, nominating and governance, compensation, science and technology, and audit committees. I leverage my expertise in product acquisitions, clinical trials, and clinical development to support the strategic vision, growth, and performance of these organizations.
-
DirectorExcision BiotherapeuticsMiami Beach, Fl, Us
-
Board Of DirectorsLutron Electronics Jan 2022 - PresentCoopersburg, Pa, UsIndependent Director and Chair of the Talent and Compensation Committee. Lutron Electronics which is privately held, specializes in energy-saving lighting, shade, and temperature control systems. -
Board Of DirectorsAnnexon Biosciences (Nasdaq: Annx) Feb 2021 - PresentIndependent Director and Chair of the Science and Technology Committee. Annexon is bringing game-changing therapies to patients suffering from serious complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders.
-
AdvisorBexson Biomedical Jun 2020 - PresentSanta Barbara, Ca, Us -
Chairman Of The BoardSozosei Foundation Jan 2020 - PresentAbout the Sozosei FoundationThe Sozosei Foundation is a U.S.-based, private charitable foundation committed to the health and well-being of our communities, including improved patient diagnosis, treatment, care and quality of life, especially for those patients who are most in need. -
DirectorExcision Biotherapeutics Dec 2019 - PresentSan Francisco , Ca, UsUNPARALLELED RESEARCH ENDLESS POSSIBILITIESThe Excision BioTherapeutics team includes some of the top biochemistry, chemistry and molecular biology experts with concentrations in the fields of retrovirology, virology, viral genetics, bioinformatics, and advanced drug delivery.AREAS OF FOCUS:Human Immunodeficiency Virus-1 TherapeuticsJC Virus and Progressive Multifocal LeukoencephalopathyHerpes Simplex Virus 1 and 2 TherapeuticsHepatitis B Virus TherapeuticsAdvanced DNA and Biologic Delivery Systems
-
Chairman Of The BoardDecibel Therapeutics (Nasdaq: Dbtx) Jun 2021 - Sep 2023
-
Chairman Of The BoardOtsuka Pharmaceutical Development & Commercialization, Inc. Jan 2020 - Apr 2023 -
DirectorSaama Nov 2019 - Nov 2021Campbell, Ca, Us -
TrusteeInternet2 Sep 2018 - Oct 2021Ann Arbor, Mi, UsInternet2 is a member-driven advanced technology community founded by the nation’s leading higher education institutions in 1996. Internet2 provides a collaborative environment where US research and education organizations can solve common technology challenges and develop innovative solutions in support of their educational, research and community service missions. Our community touches nearly every major innovation that defines our modern digital lives—and continues to define “what’s next.” Internet2 operates the nation’s largest and fastest, coast-to-coast research and education network that was built to deliver advanced, customized services that are accessed and secured by the community-developed trust and identity framework, with Internet2 Network Operations Center powered by Indiana University. Internet2 serves 317 U.S. universities, 60 government agencies, 43 regional and state education networks and through them supports more than 100,000 community anchor institutions, close to 1,000 InCommon participants, and 59 leading corporations working with our community, and 70 national research and education network partners that represent more than 100 countries. -
Board MemberPrevail Therapeutics Sep 2020 - Jan 2021New York, Us -
President & CeoOtsuka Pharmaceutical Development & Commercialization, Inc Aug 2010 - Dec 2019Princeton, Nj, UsServe as hands-on executive leader for this wholly owned subsidiary of Otsuka, Inc., which has developed compounds to treat disorders in neuroscience, oncology, and cardio-renal therapeutic areas.►Tasked by board of Otsuka Pharmaceutical Japan to lead enterprise-wide globalization effort to streamline and harmonize what was a regionally fragmented pharmacovigilance and safety program.►Entered into exclusive, worldwide license and collaboration agreement with Proteus Digital Health, Inc. to develop and commercialize new category of medicines based on Otsuka’s pharmaceutical products and Proteus’s digital health feedback system.►Delivered global clinical development outcomes including: Abilify Maintena® (long acting depot formulation) approved Feb. 2013 in US and Sept. 2013 in EU; Rexulti™ (brexpiprazole) approved July 2015 in US; and approval by Japan PMDA and EMA for tolvaptan for treatment of polycystic Kidney Disease (PKD). -
Svp, Global Clinical Development (2008-2010) Vp, Global Clinical Development (2007-2008)Otsuka Pharmaceutical Development & Commercialization 2007 - 2010Princeton, Nj, UsAdded ongoing value as head of global R&D for Otsuka’s global products. Maintained accountability for central nervous system (CNS) compounds, including Abilify (indications not being developed by BMS) and Brexpiprazole; for cardio-renal compound Tolvaptan; oncology compounds Busulfex and Sativex (developed with GW Pharma).
-
Vice President, Cns / AripiprazoleOtsuka Pharmaceutical Development & Commercialization 2002 - 2007Princeton, Nj, UsServed as clinical co-chair for Otsuka-BMS alliance for Aripiprazole leading up to approval and 2002 launch of Abilify. Established positive, ongoing relationships with worldwide colleagues.
-
Group DirectorBristol-Myers Squibb 1998 - 2002Lawrence Township, Nj, Us -
Associate Professor, Department Of PsychiatryMedical University Of South Carolina 1988 - 1998Charleston, Sc, Us
William Carson Skills
William Carson Education Details
-
Harvard Business School Executive EducationCorporate Director Certification -
Case Western Reserve University School Of MedicineMedicine
-
Harvard UniversityHistory And Science
-
Tufts University School Of MedicinePsychiatry Residency
-
Harvard Business SchoolCorporate Director Certification
Frequently Asked Questions about William Carson
What company does William Carson work for?
William Carson works for Excision Biotherapeutics
What is William Carson's role at the current company?
William Carson's current role is Director.
What is William Carson's email address?
William Carson's email address is wc****@****ltx.com
What is William Carson's direct phone number?
William Carson's direct phone number is (301)-548*****
What schools did William Carson attend?
William Carson attended Harvard Business School Executive Education, Case Western Reserve University School Of Medicine, Harvard University, Tufts University School Of Medicine, Harvard Business School.
What skills is William Carson known for?
William Carson has skills like Clinical Development, Clinical Trials, Pharmaceutical Industry, Clinical Research, Neuroscience, Commercialization, Drug Development, Medicine, Neurology, Hospitals, Strategic Planning, Cro.
Who are William Carson's colleagues?
William Carson's colleagues are Michael Walker, Joseph Saluta, Fabrizio Belotti, Xiangzhu C., Tim Pickering, Lisa Sobolewski, Oliver Lourie.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial